AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice

Existing therapies for inflammatory bowel disease that are based on broad suppression of inflammation result in variable clinical benefit and unwanted side effects. A potential therapeutic approach for promoting immune tolerance is the in vivo induction of regulatory T cells (Tregs). Here we report...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cell reports (Cambridge) Ročník 17; číslo 5; s. 1318 - 1329
Hlavní autoři:	Goettel, Jeremy A., Gandhi, Roopali, Kenison, Jessica E., Yeste, Ada, Murugaiyan, Gopal, Sambanthamoorthy, Sharmila, Griffith, Alexandra E., Patel, Bonny, Shouval, Dror S., Weiner, Howard L., Snapper, Scott B., Quintana, Francisco J.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Inc 25.10.2016 Elsevier
Témata:	AHR Animals Colitis - immunology Colitis - metabolism Disease Models, Animal Forkhead Transcription Factors - metabolism humanized mice Humans IBD ITE Mice Receptors, Aryl Hydrocarbon - metabolism T-Lymphocytes, Regulatory - immunology Thiazoles Transforming Growth Factor beta1 - pharmacology treg Trinitrobenzenesulfonic Acid IBD AHR ITE treg humanized mice
ISSN:	2211-1247, 2211-1247
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Existing therapies for inflammatory bowel disease that are based on broad suppression of inflammation result in variable clinical benefit and unwanted side effects. A potential therapeutic approach for promoting immune tolerance is the in vivo induction of regulatory T cells (Tregs). Here we report that activation of the aryl hydrocarbon receptor using the non-toxic agonist 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) induces human Tregs in vitro that suppress effector T cells through a mechanism mediated by CD39 and Granzyme B. We then developed a humanized murine system whereby human CD4+ T cells drive colitis upon exposure to 2,4,6-trinitrobenzenesulfonic acid and assessed ITE as a potential therapeutic. ITE administration ameliorated colitis in humanized mice with increased CD39, Granzyme B, and IL10-secreting human Tregs. These results develop an experimental model to investigate human CD4+ T responses in vivo and identify the non-toxic AHR agonist ITE as a potential therapy for promoting immune tolerance in the intestine. [Display omitted] •Non-toxic AHR agonist ITE induces human regulatory T cells in vitro•ITE-mediated in vitro suppression is dependent on CD39 and Granzyme B•Human CD4 T cells drive TNBS-induced colitis in humanized mice•ITE protects against TNBS-induced colitis in humanized mice Therapeutic approaches aimed at expanding regulatory T cells in the gut to promote immune tolerance in patients with inflammatory bowel disease (IBD) are of clinical significance. Goettel et al. establish a humanized murine model of IBD driven by human T cells and find that activation of AHR by the non-toxic agonist ITE can prevent experimental colitis.
AbstractList	Existing therapies for inflammatory bowel disease that are based on broad suppression of inflammation result in variable clinical benefit and unwanted side effects. A potential therapeutic approach for promoting immune tolerance is the in vivo induction of regulatory T cells (Tregs). Here we report that activation of the aryl hydrocarbon receptor using the non-toxic agonist 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) induces human Tregs in vitro that suppress effector T cells through a mechanism mediated by CD39 and Granzyme B. We then developed a humanized murine system whereby human CD4+ T cells drive colitis upon exposure to 2,4,6-trinitrobenzenesulfonic acid and assessed ITE as a potential therapeutic. ITE administration ameliorated colitis in humanized mice with increased CD39, Granzyme B, and IL10-secreting human Tregs. These results develop an experimental model to investigate human CD4+ T responses in vivo and identify the non-toxic AHR agonist ITE as a potential therapy for promoting immune tolerance in the intestine.Existing therapies for inflammatory bowel disease that are based on broad suppression of inflammation result in variable clinical benefit and unwanted side effects. A potential therapeutic approach for promoting immune tolerance is the in vivo induction of regulatory T cells (Tregs). Here we report that activation of the aryl hydrocarbon receptor using the non-toxic agonist 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) induces human Tregs in vitro that suppress effector T cells through a mechanism mediated by CD39 and Granzyme B. We then developed a humanized murine system whereby human CD4+ T cells drive colitis upon exposure to 2,4,6-trinitrobenzenesulfonic acid and assessed ITE as a potential therapeutic. ITE administration ameliorated colitis in humanized mice with increased CD39, Granzyme B, and IL10-secreting human Tregs. These results develop an experimental model to investigate human CD4+ T responses in vivo and identify the non-toxic AHR agonist ITE as a potential therapy for promoting immune tolerance in the intestine. Existing therapies for inflammatory bowel disease that are based on broad suppression of inflammation result in variable clinical benefit and unwanted side effects. A potential therapeutic approach for promoting immune tolerance is the in vivo induction of regulatory T cells (Tregs). Here we report that activation of the aryl hydrocarbon receptor using the non-toxic agonist 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) induces human Tregs in vitro that suppress effector T cells through a mechanism mediated by CD39 and Granzyme B. We then developed a humanized murine system whereby human CD4 T cells drive colitis upon exposure to 2,4,6-trinitrobenzenesulfonic acid and assessed ITE as a potential therapeutic. ITE administration ameliorated colitis in humanized mice with increased CD39, Granzyme B, and IL10-secreting human Tregs. These results develop an experimental model to investigate human CD4 T responses in vivo and identify the non-toxic AHR agonist ITE as a potential therapy for promoting immune tolerance in the intestine. Existing therapies for inflammatory bowel disease that are based on broad suppression of inflammation result in variable clinical benefit and unwanted side effects. A potential therapeutic approach for promoting immune tolerance is the in vivo induction of regulatory T cells (Tregs). Here we report that activation of the aryl hydrocarbon receptor using the non-toxic agonist 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) induces human Tregs in vitro that suppress effector T cells through a mechanism mediated by CD39 and Granzyme B. We then developed a humanized murine system whereby human CD4+ T cells drive colitis upon exposure to 2,4,6-trinitrobenzenesulfonic acid and assessed ITE as a potential therapeutic. ITE administration ameliorated colitis in humanized mice with increased CD39, Granzyme B, and IL10-secreting human Tregs. These results develop an experimental model to investigate human CD4+ T responses in vivo and identify the non-toxic AHR agonist ITE as a potential therapy for promoting immune tolerance in the intestine. [Display omitted] •Non-toxic AHR agonist ITE induces human regulatory T cells in vitro•ITE-mediated in vitro suppression is dependent on CD39 and Granzyme B•Human CD4 T cells drive TNBS-induced colitis in humanized mice•ITE protects against TNBS-induced colitis in humanized mice Therapeutic approaches aimed at expanding regulatory T cells in the gut to promote immune tolerance in patients with inflammatory bowel disease (IBD) are of clinical significance. Goettel et al. establish a humanized murine model of IBD driven by human T cells and find that activation of AHR by the non-toxic agonist ITE can prevent experimental colitis. Existing therapies for inflammatory bowel disease that are based on broad suppression of inflammation result in variable clinical benefit and unwanted side effects. A potential therapeutic approach for promoting immune tolerance is the in vivo induction of regulatory T cells (Tregs). Here we report that activation of the aryl hydrocarbon receptor using the non-toxic agonist 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) induces human Tregs in vitro that suppress effector T cells through a mechanism mediated by CD39 and Granzyme B. We then developed a humanized murine system whereby human CD4+ T cells drive colitis upon exposure to 2,4,6-trinitrobenzenesulfonic acid and assessed ITE as a potential therapeutic. ITE administration ameliorated colitis in humanized mice with increased CD39, Granzyme B, and IL10-secreting human Tregs. These results develop an experimental model to investigate human CD4+ T responses in vivo and identify the non-toxic AHR agonist ITE as a potential therapy for promoting immune tolerance in the intestine. : Therapeutic approaches aimed at expanding regulatory T cells in the gut to promote immune tolerance in patients with inflammatory bowel disease (IBD) are of clinical significance. Goettel et al. establish a humanized murine model of IBD driven by human T cells and find that activation of AHR by the non-toxic agonist ITE can prevent experimental colitis. Keywords: AHR, treg, humanized mice, IBD, ITE Existing therapies for inflammatory bowel disease based on broad suppression of inflammation result in variable clinical benefit and unwanted side effects. A potential therapeutic approach for promoting immune tolerance is the in vivo induction of regulatory T cells (Tregs). Here we report that activation of the aryl hydrocarbon receptor using the non-toxic agonist 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) induces human Tregs in vitro that suppress effector T cells through a mechanism mediated by CD39 and Granzyme B. We then developed a humanized murine system whereby human CD4+ T cells drive colitis upon exposure to 2,4,6-trinitrobenzenesulfonic acid and assessed ITE as a potential therapeutic. ITE administration ameliorated colitis in humanized mice with increased CD39, Granzyme B, and IL-10-secreting human regulatory T cells. These results develop an experimental model to investigate human CD4+ T responses in vivo and identify the non-toxic AHR agonist ITE as a potential therapy for promoting immune tolerance in the intestine.
Author	Kenison, Jessica E. Snapper, Scott B. Gandhi, Roopali Weiner, Howard L. Quintana, Francisco J. Yeste, Ada Murugaiyan, Gopal Goettel, Jeremy A. Griffith, Alexandra E. Patel, Bonny Sambanthamoorthy, Sharmila Shouval, Dror S.
AuthorAffiliation	4 Department of Neurology, Brigham and Women’s Hospital, Boston, MA 02115, USA 1 Division of Gastroenterology, Hepatology and Nutrition, Boston Children’s Hospital, Boston, MA 02115, USA 2 Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA 3 Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA 02115, USA 6 Division of Gastroenterology, Brigham and Women’s Hospital, Boston, MA 02115, USA 5 Department of Medicine, Harvard Medical School, Boston, MA 02115, USA
AuthorAffiliation_xml	– name: 1 Division of Gastroenterology, Hepatology and Nutrition, Boston Children’s Hospital, Boston, MA 02115, USA – name: 4 Department of Neurology, Brigham and Women’s Hospital, Boston, MA 02115, USA – name: 3 Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA 02115, USA – name: 6 Division of Gastroenterology, Brigham and Women’s Hospital, Boston, MA 02115, USA – name: 5 Department of Medicine, Harvard Medical School, Boston, MA 02115, USA – name: 2 Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA
Author_xml	– sequence: 1 givenname: Jeremy A. surname: Goettel fullname: Goettel, Jeremy A. organization: Division of Gastroenterology, Hepatology and Nutrition, Boston Children’s Hospital, Boston, MA 02115, USA – sequence: 2 givenname: Roopali surname: Gandhi fullname: Gandhi, Roopali organization: Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA 02115, USA – sequence: 3 givenname: Jessica E. surname: Kenison fullname: Kenison, Jessica E. organization: Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA 02115, USA – sequence: 4 givenname: Ada surname: Yeste fullname: Yeste, Ada organization: Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA 02115, USA – sequence: 5 givenname: Gopal surname: Murugaiyan fullname: Murugaiyan, Gopal organization: Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA 02115, USA – sequence: 6 givenname: Sharmila surname: Sambanthamoorthy fullname: Sambanthamoorthy, Sharmila organization: Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA 02115, USA – sequence: 7 givenname: Alexandra E. surname: Griffith fullname: Griffith, Alexandra E. organization: Division of Gastroenterology, Hepatology and Nutrition, Boston Children’s Hospital, Boston, MA 02115, USA – sequence: 8 givenname: Bonny surname: Patel fullname: Patel, Bonny organization: Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA 02115, USA – sequence: 9 givenname: Dror S. surname: Shouval fullname: Shouval, Dror S. organization: Division of Gastroenterology, Hepatology and Nutrition, Boston Children’s Hospital, Boston, MA 02115, USA – sequence: 10 givenname: Howard L. surname: Weiner fullname: Weiner, Howard L. organization: Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA 02115, USA – sequence: 11 givenname: Scott B. surname: Snapper fullname: Snapper, Scott B. email: scott.snapper@childrens.harvard.edu organization: Division of Gastroenterology, Hepatology and Nutrition, Boston Children’s Hospital, Boston, MA 02115, USA – sequence: 12 givenname: Francisco J. surname: Quintana fullname: Quintana, Francisco J. email: fquintana@rics.bwh.harvard.edu organization: Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA 02115, USA
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/27783946$$D View this record in MEDLINE/PubMed
BookMark	eNqFkk1vEzEQhi1URD_oP0DIRy5Z_LXeNQekKIUmUhEVKmfLa88GRxs72JtI5dfjNKFqOYAv9ozfeceax-foJMQACL2hpKKEyverysKQYFOxElVEVaRlL9AZY5ROKBPNyZPzKbrMeUXKkoRSJV6hU9Y0LVdCnqHb6fwbntrR78zoY8CLjG9THGGfAWyWxoc84lkc_OgzvkolG3B3j-_wDIYhYx_wfLs2wf8Ch794C6_Ry94MGS6P-wX6_vnT3Ww-ufl6vZhNbya2ZmqcKAAmZcek4qTnRpiadx2vW-laZpy0Dgzta9r2ggProeENWCV665TsqGkMv0CLg6-LZqU3ya9NutfReP2QiGmpTRq9HUB3TjQCXC0oUOFUbbreMaBgasaVpKJ4fTx4bbbdGpyFMCYzPDN9fhP8D72MO11TItuGF4N3R4MUf24hj3rtcyE0mABxmzVteS1bzhkp0rdPez02-YOkCMRBYFPMOUH_KKFE7-HrlT7A13v4mihd4JeyD3-VWT8-MC0v9sP_io8DgEJs5yHpbD0EC86n8hXKSP2_DX4DEU7M7g
CitedBy_id	crossref_primary_10_1016_j_phrs_2020_105180 crossref_primary_10_3390_nu15234980 crossref_primary_10_1038_s41590_020_0802_6 crossref_primary_10_1016_j_coi_2021_02_003 crossref_primary_10_1134_S0003683824604670 crossref_primary_10_1111_all_15455 crossref_primary_10_1016_j_biochi_2022_12_014 crossref_primary_10_1155_2020_9706140 crossref_primary_10_1074_jbc_RA119_008882 crossref_primary_10_3389_fphar_2020_596357 crossref_primary_10_1093_function_zqaf001 crossref_primary_10_1002_JLB_2AB0518_205RR crossref_primary_10_1016_j_cotox_2017_02_002 crossref_primary_10_1038_s41467_019_08581_8 crossref_primary_10_3390_cells11152296 crossref_primary_10_1038_s41385_018_0019_2 crossref_primary_10_3389_fmicb_2022_846555 crossref_primary_10_3390_ijms22179460 crossref_primary_10_1038_s41591_021_01390_x crossref_primary_10_1016_j_jaut_2018_07_022 crossref_primary_10_1146_annurev_immunol_071219_125715 crossref_primary_10_1016_j_autrev_2024_103583 crossref_primary_10_1038_s41598_018_37019_2 crossref_primary_10_4049_jimmunol_1701734 crossref_primary_10_1016_j_it_2022_07_001 crossref_primary_10_1161_JAHA_120_020502 crossref_primary_10_3390_ph17010084 crossref_primary_10_3389_fimmu_2019_00507 crossref_primary_10_3389_fimmu_2021_671648 crossref_primary_10_1016_j_coi_2021_02_006 crossref_primary_10_1038_s41423_022_00943_5 crossref_primary_10_3390_cells14181467 crossref_primary_10_3390_ijms23010288 crossref_primary_10_3389_fimmu_2021_637960 crossref_primary_10_1016_j_bcp_2021_114417 crossref_primary_10_1096_fj_202001529R crossref_primary_10_3389_fimmu_2019_00091 crossref_primary_10_1038_s41467_021_22727_7 crossref_primary_10_3390_cells9102294 crossref_primary_10_1007_s00109_017_1545_1 crossref_primary_10_1016_j_taap_2019_114772 crossref_primary_10_1186_s13148_022_01330_7 crossref_primary_10_3389_fnut_2022_842298 crossref_primary_10_3389_fimmu_2024_1331518 crossref_primary_10_1038_s41467_018_05470_4 crossref_primary_10_1186_s12876_019_1009_x crossref_primary_10_1038_s41586_022_05308_6 crossref_primary_10_1016_j_phymed_2023_154874 crossref_primary_10_1177_1178646920928984 crossref_primary_10_1152_ajpgi_00236_2025 crossref_primary_10_3390_ijms231911209 crossref_primary_10_1158_1940_6207_CAPR_21_0378 crossref_primary_10_1097_MOG_0000000000000478 crossref_primary_10_1080_10408444_2020_1773759 crossref_primary_10_1016_j_cotox_2018_03_001 crossref_primary_10_3389_fimmu_2022_795089 crossref_primary_10_3389_fcimb_2022_1017165 crossref_primary_10_1007_s11888_017_0362_9 crossref_primary_10_1016_j_freeradbiomed_2020_11_018 crossref_primary_10_1038_s41573_025_01172_x crossref_primary_10_3390_ijms20030528 crossref_primary_10_1007_s00204_018_2380_z crossref_primary_10_3390_ijms22041623 crossref_primary_10_3389_fimmu_2025_1668173 crossref_primary_10_1038_s41589_021_00807_5 crossref_primary_10_1038_s41536_023_00339_7 crossref_primary_10_3390_jcm10153334 crossref_primary_10_3390_ijms21082799 crossref_primary_10_3390_cells10092204 crossref_primary_10_1073_pnas_2016451117 crossref_primary_10_3390_ijms25084527 crossref_primary_10_1002_med_21752 crossref_primary_10_1016_j_fct_2024_114476 crossref_primary_10_1016_j_bioactmat_2024_03_030 crossref_primary_10_3390_ijms232314919 crossref_primary_10_1136_gutjnl_2023_329543 crossref_primary_10_1038_s41467_018_07859_7 crossref_primary_10_1016_j_immuni_2017_12_012 crossref_primary_10_3389_fimmu_2021_630204 crossref_primary_10_3390_biomedicines12122912 crossref_primary_10_1007_s12016_020_08789_3 crossref_primary_10_1016_j_cotox_2017_01_007 crossref_primary_10_1016_j_jnutbio_2023_109494 crossref_primary_10_1038_s41423_025_01295_6 crossref_primary_10_1016_j_jaci_2020_05_023 crossref_primary_10_1186_s11658_022_00397_7 crossref_primary_10_3390_cells10081847 crossref_primary_10_1016_j_chom_2024_06_013 crossref_primary_10_1136_bmjgast_2021_000813 crossref_primary_10_1093_procel_pwad028 crossref_primary_10_1016_j_biopha_2023_114295 crossref_primary_10_1182_bloodadvances_2017004358 crossref_primary_10_3390_ijms20174234 crossref_primary_10_3390_ijms26189160 crossref_primary_10_1097_MOH_0000000000000432 crossref_primary_10_3389_fimmu_2020_01882 crossref_primary_10_1093_ibd_izz075 crossref_primary_10_1016_j_jaci_2023_07_022 crossref_primary_10_3390_cells12050793 crossref_primary_10_1074_jbc_R116_767723 crossref_primary_10_3389_fimmu_2024_1518779 crossref_primary_10_1093_ibd_izaf141 crossref_primary_10_1016_j_canlet_2023_216582 crossref_primary_10_3389_fmicb_2023_1291724 crossref_primary_10_1113_JP275325 crossref_primary_10_3390_ijms19061654 crossref_primary_10_3390_nu12051434 crossref_primary_10_1016_j_ejmech_2022_114845 crossref_primary_10_1080_10408398_2021_1934813 crossref_primary_10_3390_ijms21207740 crossref_primary_10_1038_s41467_023_43211_4 crossref_primary_10_1016_j_bcp_2019_113671 crossref_primary_10_3389_fcell_2020_621760 crossref_primary_10_3389_fimmu_2024_1494570 crossref_primary_10_1093_nar_gky787 crossref_primary_10_1111_bph_15002 crossref_primary_10_1128_mSystems_00985_20 crossref_primary_10_1073_pnas_2012692118 crossref_primary_10_3389_fimmu_2024_1397072 crossref_primary_10_1038_s41598_021_00641_8 crossref_primary_10_1080_13880209_2023_2233565 crossref_primary_10_3389_fimmu_2021_670324 crossref_primary_10_1073_pnas_2114336119 crossref_primary_10_1146_annurev_nutr_043020_090050 crossref_primary_10_3390_ijms25063372 crossref_primary_10_1007_s40778_020_00184_0 crossref_primary_10_1016_j_bcp_2025_117066 crossref_primary_10_1016_j_freeradbiomed_2022_03_025 crossref_primary_10_1016_j_yexcr_2017_03_055 crossref_primary_10_1155_2020_5918587 crossref_primary_10_3389_fimmu_2024_1421346 crossref_primary_10_3390_ijms21186654 crossref_primary_10_3389_fvets_2020_00340 crossref_primary_10_1002_advs_202416324 crossref_primary_10_1038_s41423_020_00585_5 crossref_primary_10_4049_jimmunol_2100936 crossref_primary_10_1002_cac2_12182 crossref_primary_10_1186_s13578_023_01046_y crossref_primary_10_1016_j_mucimm_2023_09_003 crossref_primary_10_1084_jem_20232055 crossref_primary_10_1016_j_imlet_2020_03_007 crossref_primary_10_1073_pnas_2424009122 crossref_primary_10_1038_s41467_020_19692_y
Cites_doi	10.1016/j.autrev.2013.06.002 10.1038/ni.1915 10.2217/imt.09.24 10.1084/jem.182.5.1281 10.1007/s10620-011-1643-9 10.1097/MIB.0b013e318281f5a3 10.1016/j.bbrc.2008.07.156 10.1182/blood-2007-06-094656 10.1093/toxsci/kfq360 10.1016/j.immuni.2004.09.002 10.1038/nri2095 10.1084/jem.20030152 10.1038/nature10209 10.1371/journal.pone.0023522 10.1093/intimm/dxv015 10.1111/j.1600-065X.1996.tb00898.x 10.4049/jimmunol.174.10.6477 10.1038/nature11582 10.1038/ncomms4199 10.1038/ni.2363 10.1038/nbt.2858 10.1038/83713 10.1038/ni.1912 10.1182/blood-2014-12-618363 10.3949/ccjm.73.3.251 10.1056/NEJMoa0907206 10.1016/j.molimm.2012.09.007 10.1038/nature06880 10.1002/ibd.21463 10.1038/nature06881 10.1146/annurev.immunol.25.022106.141623 10.1038/13748 10.1124/pr.114.009001 10.1038/ncomms4753 10.1074/jbc.M500966200 10.1016/0092-8674(93)80068-P 10.4049/jimmunol.0803474 10.1038/194146a0 10.1084/jem.20062512 10.1002/eji.200324115 10.1038/nri2785 10.1038/icb.2010.165 10.1007/s10620-015-3632-x 10.1073/pnas.1009201107 10.1056/NEJMoa1105143 10.1038/nature12331 10.1182/blood-2006-12-064527 10.1136/gutjnl-2014-306919 10.1016/S0140-6736(61)90693-6 10.1038/icb.2014.2 10.1167/iovs.09-3993 10.1056/NEJMoa1108188 10.1038/nbt.2786 10.1002/eji.1830270722 10.1136/gutjnl-2015-310022 10.1136/gutjnl-2011-301133 10.1371/journal.pone.0023618 10.1016/j.coph.2015.05.013 10.1038/icb.2010.35 10.1038/ni.2025 10.1126/science.1135245 10.1073/pnas.1120611109 10.1038/nm.3868 10.1016/j.immuni.2013.08.002 10.1053/j.gastro.2011.04.007 10.1126/science.1093933 10.1053/j.gastro.2012.07.116 10.1073/pnas.232562899 10.1038/39614 10.1084/jem.20081438 10.1073/pnas.1017854108
ContentType	Journal Article
Copyright	2016 The Authors Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.
Copyright_xml	– notice: 2016 The Authors – notice: Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.
DBID	6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA
DOI	10.1016/j.celrep.2016.09.082
DatabaseName	ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals (DOAJ)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: DOA name: DOAJ - Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	2211-1247
EndPage	1329
ExternalDocumentID	oai_doaj_org_article_bd474ed541e14d95abfd2e1ea5239614 PMC5106873 27783946 10_1016_j_celrep_2016_09_082 S2211124716313559
Genre	Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NIAID NIH HHS grantid: R00 AI075285 – fundername: NIEHS NIH HHS grantid: R01 ES025530 – fundername: NIAID NIH HHS grantid: R01 AI093903 – fundername: NIDDK NIH HHS grantid: P30 DK034854 – fundername: NIDDK NIH HHS grantid: T32 DK007477 – fundername: NIAID NIH HHS grantid: K99 AI075285 – fundername: NIAID NIH HHS grantid: R01 AI126880 – fundername: NIDDK NIH HHS grantid: K01 DK106311 – fundername: NIAID NIH HHS grantid: R56 AI093903
GroupedDBID	0R~ 0SF 4.4 457 53G 5VS 6I. AACTN AAEDT AAEDW AAFTH AAIKJ AAKRW AALRI AAUCE AAXJY AAXUO ABMAC ABMWF ACGFO ACGFS ADBBV ADEZE AENEX AEXQZ AFTJW AGHFR AITUG ALKID ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BCNDV DIK EBS EJD FCP FDB FRP GROUPED_DOAJ GX1 IPNFZ IXB KQ8 M41 M48 NCXOZ O-L O9- OK1 RCE RIG ROL SSZ AAMRU AAYWO AAYXX ACVFH ADCNI ADVLN AEUPX AFPUW AIGII AKBMS AKRWK AKYEP APXCP CITATION HZ~ CGR CUY CVF ECM EIF NPM 7X8 5PM
ID	FETCH-LOGICAL-c529t-9ee266b26930f3a4a53bb3586d82ad6cdea1f518f43e2fe737ec94fcd96b1a7a3
IEDL.DBID	DOA
ISICitedReferencesCount	159
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000386527100011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2211-1247
IngestDate	Fri Oct 03 12:42:41 EDT 2025 Tue Sep 30 16:56:52 EDT 2025 Sun Nov 09 09:23:12 EST 2025 Thu Apr 03 07:04:09 EDT 2025 Wed Nov 05 20:52:28 EST 2025 Tue Nov 18 21:32:37 EST 2025 Wed May 17 01:06:26 EDT 2023
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	5
Keywords	IBD AHR ITE treg humanized mice
Language	English
License	This is an open access article under the CC BY-NC-ND license. Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c529t-9ee266b26930f3a4a53bb3586d82ad6cdea1f518f43e2fe737ec94fcd96b1a7a3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Co-first author Lead contact
OpenAccessLink	https://doaj.org/article/bd474ed541e14d95abfd2e1ea5239614
PMID	27783946
PQID	1835683320
PQPubID	23479
PageCount	12
ParticipantIDs	doaj_primary_oai_doaj_org_article_bd474ed541e14d95abfd2e1ea5239614 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5106873 proquest_miscellaneous_1835683320 pubmed_primary_27783946 crossref_primary_10_1016_j_celrep_2016_09_082 crossref_citationtrail_10_1016_j_celrep_2016_09_082 elsevier_sciencedirect_doi_10_1016_j_celrep_2016_09_082
PublicationCentury	2000
PublicationDate	2016-10-25
PublicationDateYYYYMMDD	2016-10-25
PublicationDate_xml	– month: 10 year: 2016 text: 2016-10-25 day: 25
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Cell reports (Cambridge)
PublicationTitleAlternate	Cell Rep
PublicationYear	2016
Publisher	Elsevier Inc Elsevier
Publisher_xml	– name: Elsevier Inc – name: Elsevier
References	Quintana, Basso, Iglesias, Korn, Farez, Bettelli, Caccamo, Oukka, Weiner (bib49) 2008; 453 Gandhi, Kumar, Burns, Nadeau, Dake, Laroni, Kozoriz, Weiner, Quintana (bib23) 2010; 11 Qiu, Guo, Chen, He, Sonnenberg, Artis, Fu, Zhou (bib48) 2013; 39 Arsenescu, Arsenescu, Zhong, Nasser, Melinte, Dingle, Swanson, de Villiers (bib2) 2011; 17 Chen, Jin, Hardegen, Lei, Li, Marinos, McGrady, Wahl (bib13) 2003; 198 Atarashi, Tanoue, Oshima, Suda, Nagano, Nishikawa, Fukuda, Saito, Narushima, Hase (bib3) 2013; 500 Desreumaux, Foussat, Allez, Beaugerie, Hebuterne, Bouhnik, Nachury, Brun, Bastian, Belmonte (bib16) 2012; 143 Rubtsov, Rudensky (bib53) 2007; 7 Neurath, Fuss, Pasparakis, Alexopoulou, Haralambous, Meyer zum Büschenfelde, Strober, Kollias (bib46) 1997; 27 Scheiffele, Fuss (bib57) 2002; 49 Singh, Singh, Singh, Price, Nagarkatti, Nagarkatti (bib59) 2011; 6 Takamura, Harama, Fukumoto, Nakamura, Shimokawa, Ishimaru, Ikegami, Makino, Kitamura, Nakao (bib63) 2011; 89 Fischer, Zundler, Atreya, Rath, Voskens, Hirschmann, López-Posadas, Watson, Becker, Schuler (bib20) 2016; 65 Kühn, Löhler, Rennick, Rajewsky, Müller (bib38) 1993; 75 Song, Clagett-Dame, Peterson, Hahn, Westler, Sicinski, DeLuca (bib60) 2002; 99 Quintana, Jin, Burns, Nadeau, Yeste, Kumar, Rangachari, Zhu, Xiao, Seavitt (bib51) 2012; 13 Glocker, Kotlarz, Boztug, Gertz, Schäffer, Noyan, Perro, Diestelhorst, Allroth, Murugan (bib24) 2009; 361 Saadoun, Rosenzwajg, Joly, Six, Carrat, Thibault, Sene, Cacoub, Klatzmann (bib54) 2011; 365 Deaglio, Dwyer, Gao, Friedman, Usheva, Erat, Chen, Enjyoji, Linden, Oukka (bib15) 2007; 204 Calabrese (bib10) 2006; 73 Veldhoen, Hirota, Westendorf, Buer, Dumoutier, Renauld, Stockinger (bib66) 2008; 453 Huang, Jiang, Yang, Shao, Sun, Chen, Dong, Zhang (bib31) 2013; 53 Le Douarin, Corbel, Bandeira, Thomas-Vaslin, Modigliani, Coutinho, Salaün (bib39) 1996; 149 Ji, Xu, Sun, Yu, Peng, Qiu, Xiao, Yang (bib32) 2015; 60 Sakaguchi, Miyara, Costantino, Hafler (bib55) 2010; 10 Koreth, Matsuoka, Kim, McDonough, Bindra, Alyea, Armand, Cutler, Ho, Treister (bib37) 2011; 365 Shultz, Lyons, Burzenski, Gott, Chen, Chaleff, Kotb, Gillies, King, Mangada (bib58) 2005; 174 Mayne, Williams (bib41) 2013; 19 Beaugerie (bib4) 2012; 61 Vogel, Goth, Dong, Pessah, Matsumura (bib68) 2008; 375 Apetoh, Quintana, Pot, Joller, Xiao, Kumar, Burns, Sherr, Weiner, Kuchroo (bib1) 2010; 11 Hollenbach, Vieth, Roessner, Neumann, Malfertheiner, Naumann (bib30) 2005; 280 Fukumoto, Toshimitsu, Matsuoka, Maruyama, Oh-Oka, Takamura, Nakamura, Ishimaru, Fujii-Kuriyama, Ikegami (bib21) 2014; 92 Chatenoud (bib12) 2015; 23 Zhang, Ma, Takeuchi, Usui, Hattori, Okunuki, Yamakawa, Kezuka, Kuroda, Goto (bib72) 2009; 51 Jostins, Ripke, Weersma, Duerr, McGovern, Hui, Lee, Schumm, Sharma, Anderson (bib34) 2012; 491 Kerkvliet, Steppan, Vorachek, Oda, Farrer, Wong, Pham, Mourich (bib35) 2009; 1 Furumatsu, Nishiumi, Kawano, Ooi, Yoshie, Shiomi, Kutsumi, Ashida, Fujii-Kuriyama, Azuma, Yoshida (bib22) 2011; 56 Persidis (bib47) 1999; 17 Goettel, Biswas, Lexmond, Yeste, Passerini, Patel, Yang, Sun, Ouahed, Shouval (bib25) 2015; 125 Esser, Rannug (bib18) 2015; 67 Bennett, Christie, Ramsdell, Brunkow, Ferguson, Whitesell, Kelly, Saulsbury, Chance, Ochs (bib6) 2001; 27 Ben-Horin, Kopylov, Chowers (bib5) 2014; 13 Sarin, Wu, Abraham (bib56) 2011; 108 Tran, Ramsey, Shevach (bib65) 2007; 110 Yeste, Nadeau, Burns, Weiner, Quintana (bib70) 2012; 109 Canavan, Scottà, Vossenkämper, Goldberg, Elder, Shoval, Marks, Stolarczyk, Lo, Powell (bib11) 2016; 65 Grossman, Verbsky, Barchet, Colonna, Atkinson, Ley (bib26) 2004; 21 Sonnenberg, Fouser, Artis (bib61) 2011; 12 Traggiai, Chicha, Mazzucchelli, Bronz, Piffaretti, Lanzavecchia, Manz (bib64) 2004; 304 Miller (bib42) 1961; 2 Hay, Thomas, Craighead, Economides, Rosenthal (bib29) 2014; 32 Khor, Gardet, Xavier (bib36) 2011; 474 Moncrieffe, Nistala, Kamhieh, Evans, Eddaoudi, Eaton, Wedderburn (bib43) 2010; 185 Veldhoen, Hirota, Christensen, O’Garra, Stockinger (bib67) 2009; 206 Neurath, Fuss, Kelsall, Stüber, Strober (bib45) 1995; 182 Burnet, Holmes (bib9) 1962; 194 Chinen, Nakahama, Kimura, Nguyen, Takemori, Kumagai, Kayama, Takeda, Lee, Hanieh (bib14) 2015; 27 Evans, Roostalu, Walter, Gullick, Frederiksen, Roberts, Sumner, Baeten, Gerwien, Cope (bib19) 2014; 5 Borsellino, Kleinewietfeld, Di Mitri, Sternjak, Diamantini, Giometto, Höpner, Centonze, Bernardi, Dell’Acqua (bib8) 2007; 110 Takamura, Harama, Matsuoka, Shimokawa, Nakamura, Okumura, Ogawa, Kitamura, Nakao (bib62) 2010; 88 Duerr, Taylor, Brant, Rioux, Silverberg, Daly, Steinhart, Abraham, Regueiro, Griffiths (bib17) 2006; 314 Benson, Shepherd (bib7) 2011; 120 Hauet-Broere, Unger, Garssen, Hoijer, Kraal, Samsom (bib28) 2003; 33 Josefowicz, Lu, Rudensky (bib33) 2012; 30 Quintana, Murugaiyan, Farez, Mitsdoerffer, Tukpah, Burns, Weiner (bib50) 2010; 107 Rongvaux, Willinger, Martinek, Strowig, Gearty, Teichmann, Saito, Marches, Halene, Palucka (bib52) 2014; 32 Groux, O’Garra, Bigler, Rouleau, Antonenko, de Vries, Roncarolo (bib27) 1997; 389 Yeste, Mascanfroni, Nadeau, Burns, Tukpah, Santiago, Wu, Patel, Kumar, Quintana (bib71) 2014; 5 Wu, Quintana, da Cunha, Dake, Koeglsperger, Starossom, Weiner (bib69) 2011; 6 Monteleone, Rizzo, Sarra, Sica, Sileri, Biancone, MacDonald, Pallone, Monteleone (bib44) 2011; 141 Mascanfroni, Takenaka, Yeste, Patel, Wu, Kenison, Siddiqui, Basso, Otterbein, Pardoll (bib40) 2015; 21 Esser (10.1016/j.celrep.2016.09.082_bib18) 2015; 67 Borsellino (10.1016/j.celrep.2016.09.082_bib8) 2007; 110 Hay (10.1016/j.celrep.2016.09.082_bib29) 2014; 32 Khor (10.1016/j.celrep.2016.09.082_bib36) 2011; 474 Sakaguchi (10.1016/j.celrep.2016.09.082_bib55) 2010; 10 Traggiai (10.1016/j.celrep.2016.09.082_bib64) 2004; 304 Shultz (10.1016/j.celrep.2016.09.082_bib58) 2005; 174 Miller (10.1016/j.celrep.2016.09.082_bib42) 1961; 2 Deaglio (10.1016/j.celrep.2016.09.082_bib15) 2007; 204 Evans (10.1016/j.celrep.2016.09.082_bib19) 2014; 5 Kerkvliet (10.1016/j.celrep.2016.09.082_bib35) 2009; 1 Benson (10.1016/j.celrep.2016.09.082_bib7) 2011; 120 Beaugerie (10.1016/j.celrep.2016.09.082_bib4) 2012; 61 Sarin (10.1016/j.celrep.2016.09.082_bib56) 2011; 108 Saadoun (10.1016/j.celrep.2016.09.082_bib54) 2011; 365 Huang (10.1016/j.celrep.2016.09.082_bib31) 2013; 53 Quintana (10.1016/j.celrep.2016.09.082_bib50) 2010; 107 Neurath (10.1016/j.celrep.2016.09.082_bib46) 1997; 27 Goettel (10.1016/j.celrep.2016.09.082_bib25) 2015; 125 Ji (10.1016/j.celrep.2016.09.082_bib32) 2015; 60 Josefowicz (10.1016/j.celrep.2016.09.082_bib33) 2012; 30 Desreumaux (10.1016/j.celrep.2016.09.082_bib16) 2012; 143 Chinen (10.1016/j.celrep.2016.09.082_bib14) 2015; 27 Koreth (10.1016/j.celrep.2016.09.082_bib37) 2011; 365 Burnet (10.1016/j.celrep.2016.09.082_bib9) 1962; 194 Mayne (10.1016/j.celrep.2016.09.082_bib41) 2013; 19 Glocker (10.1016/j.celrep.2016.09.082_bib24) 2009; 361 Bennett (10.1016/j.celrep.2016.09.082_bib6) 2001; 27 Canavan (10.1016/j.celrep.2016.09.082_bib11) 2016; 65 Duerr (10.1016/j.celrep.2016.09.082_bib17) 2006; 314 Takamura (10.1016/j.celrep.2016.09.082_bib62) 2010; 88 Hauet-Broere (10.1016/j.celrep.2016.09.082_bib28) 2003; 33 Monteleone (10.1016/j.celrep.2016.09.082_bib44) 2011; 141 Mascanfroni (10.1016/j.celrep.2016.09.082_bib40) 2015; 21 Yeste (10.1016/j.celrep.2016.09.082_bib71) 2014; 5 Le Douarin (10.1016/j.celrep.2016.09.082_bib39) 1996; 149 Tran (10.1016/j.celrep.2016.09.082_bib65) 2007; 110 Rubtsov (10.1016/j.celrep.2016.09.082_bib53) 2007; 7 Kühn (10.1016/j.celrep.2016.09.082_bib38) 1993; 75 Persidis (10.1016/j.celrep.2016.09.082_bib47) 1999; 17 Calabrese (10.1016/j.celrep.2016.09.082_bib10) 2006; 73 Scheiffele (10.1016/j.celrep.2016.09.082_bib57) 2002; 49 Ben-Horin (10.1016/j.celrep.2016.09.082_bib5) 2014; 13 Furumatsu (10.1016/j.celrep.2016.09.082_bib22) 2011; 56 Sonnenberg (10.1016/j.celrep.2016.09.082_bib61) 2011; 12 Chatenoud (10.1016/j.celrep.2016.09.082_bib12) 2015; 23 Quintana (10.1016/j.celrep.2016.09.082_bib51) 2012; 13 Hollenbach (10.1016/j.celrep.2016.09.082_bib30) 2005; 280 Zhang (10.1016/j.celrep.2016.09.082_bib72) 2009; 51 Vogel (10.1016/j.celrep.2016.09.082_bib68) 2008; 375 Wu (10.1016/j.celrep.2016.09.082_bib69) 2011; 6 Veldhoen (10.1016/j.celrep.2016.09.082_bib66) 2008; 453 Song (10.1016/j.celrep.2016.09.082_bib60) 2002; 99 Veldhoen (10.1016/j.celrep.2016.09.082_bib67) 2009; 206 Yeste (10.1016/j.celrep.2016.09.082_bib70) 2012; 109 Qiu (10.1016/j.celrep.2016.09.082_bib48) 2013; 39 Atarashi (10.1016/j.celrep.2016.09.082_bib3) 2013; 500 Fischer (10.1016/j.celrep.2016.09.082_bib20) 2016; 65 Fukumoto (10.1016/j.celrep.2016.09.082_bib21) 2014; 92 Rongvaux (10.1016/j.celrep.2016.09.082_bib52) 2014; 32 Gandhi (10.1016/j.celrep.2016.09.082_bib23) 2010; 11 Grossman (10.1016/j.celrep.2016.09.082_bib26) 2004; 21 Jostins (10.1016/j.celrep.2016.09.082_bib34) 2012; 491 Takamura (10.1016/j.celrep.2016.09.082_bib63) 2011; 89 Moncrieffe (10.1016/j.celrep.2016.09.082_bib43) 2010; 185 Apetoh (10.1016/j.celrep.2016.09.082_bib1) 2010; 11 Arsenescu (10.1016/j.celrep.2016.09.082_bib2) 2011; 17 Quintana (10.1016/j.celrep.2016.09.082_bib49) 2008; 453 Neurath (10.1016/j.celrep.2016.09.082_bib45) 1995; 182 Groux (10.1016/j.celrep.2016.09.082_bib27) 1997; 389 Singh (10.1016/j.celrep.2016.09.082_bib59) 2011; 6 Chen (10.1016/j.celrep.2016.09.082_bib13) 2003; 198
References_xml	– volume: 11 start-page: 854 year: 2010 end-page: 861 ident: bib1 article-title: The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27 publication-title: Nat. Immunol. – volume: 88 start-page: 685 year: 2010 end-page: 689 ident: bib62 article-title: Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice publication-title: Immunol. Cell Biol. – volume: 21 start-page: 638 year: 2015 end-page: 646 ident: bib40 article-title: Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α publication-title: Nat. Med. – volume: 21 start-page: 589 year: 2004 end-page: 601 ident: bib26 article-title: Human T regulatory cells can use the perforin pathway to cause autologous target cell death publication-title: Immunity – volume: 89 start-page: 817 year: 2011 end-page: 822 ident: bib63 article-title: Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis publication-title: Immunol. Cell Biol. – volume: 141 start-page: 237 year: 2011 end-page: 248, 248.e1 ident: bib44 article-title: Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract publication-title: Gastroenterology – volume: 27 start-page: 405 year: 2015 end-page: 415 ident: bib14 article-title: The aryl hydrocarbon receptor/microRNA-212/132 axis in T cells regulates IL-10 production to maintain intestinal homeostasis publication-title: Int. Immunol. – volume: 109 start-page: 11270 year: 2012 end-page: 11275 ident: bib70 article-title: Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis publication-title: Proc. Natl. Acad. Sci. USA – volume: 51 start-page: 2109 year: 2009 end-page: 2117 ident: bib72 article-title: Activation of aryl hydrocarbon receptor suppresses experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells publication-title: Invest. Ophthalmol. Vis. Sci. – volume: 61 start-page: 476 year: 2012 end-page: 483 ident: bib4 article-title: Inflammatory bowel disease therapies and cancer risk: where are we and where are we going? publication-title: Gut – volume: 6 start-page: e23522 year: 2011 ident: bib59 article-title: Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis publication-title: PLoS ONE – volume: 30 start-page: 531 year: 2012 end-page: 564 ident: bib33 article-title: Regulatory T cells: mechanisms of differentiation and function publication-title: Annu. Rev. Immunol. – volume: 204 start-page: 1257 year: 2007 end-page: 1265 ident: bib15 article-title: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression publication-title: J. Exp. Med. – volume: 49 year: 2002 ident: bib57 article-title: Induction of TNBS colitis in mice publication-title: Curr. Protoc. Immunol. – volume: 314 start-page: 1461 year: 2006 end-page: 1463 ident: bib17 article-title: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene publication-title: Science – volume: 365 start-page: 2067 year: 2011 end-page: 2077 ident: bib54 article-title: Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis publication-title: N. Engl. J. Med. – volume: 19 start-page: 1772 year: 2013 end-page: 1788 ident: bib41 article-title: Induced and natural regulatory T cells in the development of inflammatory bowel disease publication-title: Inflamm. Bowel Dis. – volume: 99 start-page: 14694 year: 2002 end-page: 14699 ident: bib60 article-title: A ligand for the aryl hydrocarbon receptor isolated from lung publication-title: Proc. Natl. Acad. Sci. USA – volume: 60 start-page: 1958 year: 2015 end-page: 1966 ident: bib32 article-title: Aryl hydrocarbon receptor activation down-regulates IL-7 and reduces inflammation in a mouse model of mouse model publication-title: Dig. Dis. Sci. – volume: 174 start-page: 6477 year: 2005 end-page: 6489 ident: bib58 article-title: Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells publication-title: J. Immunol. – volume: 17 start-page: 1149 year: 2011 end-page: 1162 ident: bib2 article-title: Role of the xenobiotic receptor in inflammatory bowel disease publication-title: Inflamm. Bowel Dis. – volume: 280 start-page: 14981 year: 2005 end-page: 14988 ident: bib30 article-title: Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease publication-title: J. Biol. Chem. – volume: 1 start-page: 539 year: 2009 end-page: 547 ident: bib35 article-title: Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes publication-title: Immunotherapy – volume: 206 start-page: 43 year: 2009 end-page: 49 ident: bib67 article-title: Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells publication-title: J. Exp. Med. – volume: 182 start-page: 1281 year: 1995 end-page: 1290 ident: bib45 article-title: Antibodies to interleukin 12 abrogate established experimental colitis in mice publication-title: J. Exp. Med. – volume: 143 year: 2012 ident: bib16 article-title: Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn’s disease publication-title: Gastroenterology – volume: 65 start-page: 1642 year: 2016 end-page: 1664 ident: bib20 article-title: Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo publication-title: Gut – volume: 75 start-page: 263 year: 1993 end-page: 274 ident: bib38 article-title: Interleukin-10-deficient mice develop chronic enterocolitis publication-title: Cell – volume: 73 start-page: 251 year: 2006 end-page: 256 ident: bib10 article-title: The yin and yang of tumor necrosis factor inhibitors publication-title: Cleve. Clin. J. Med. – volume: 7 start-page: 443 year: 2007 end-page: 453 ident: bib53 article-title: TGFbeta signalling in control of T-cell-mediated self-reactivity publication-title: Nat. Rev. Immunol. – volume: 12 start-page: 383 year: 2011 end-page: 390 ident: bib61 article-title: Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 publication-title: Nat. Immunol. – volume: 23 start-page: 92 year: 2015 end-page: 97 ident: bib12 article-title: Biotherapies targeting T and B cells: from immune suppression to immune tolerance publication-title: Curr. Opin. Pharmacol. – volume: 13 start-page: 24 year: 2014 end-page: 30 ident: bib5 article-title: Optimizing anti-TNF treatments in inflammatory bowel disease publication-title: Autoimmun. Rev. – volume: 67 start-page: 259 year: 2015 end-page: 279 ident: bib18 article-title: The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology publication-title: Pharmacol. Rev. – volume: 5 start-page: 3199 year: 2014 ident: bib19 article-title: TNF-α blockade induces IL-10 expression in human CD4+ T cells publication-title: Nat. Commun. – volume: 107 start-page: 20768 year: 2010 end-page: 20773 ident: bib50 article-title: An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis publication-title: Proc. Natl. Acad. Sci. USA – volume: 194 start-page: 146 year: 1962 end-page: 147 ident: bib9 article-title: Immunological function of thymus and bursa of Fabricius. Thymus lesions in an auto-immune disease of mice publication-title: Nature – volume: 6 start-page: e23618 year: 2011 ident: bib69 article-title: In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling publication-title: PLoS ONE – volume: 5 start-page: 3753 year: 2014 ident: bib71 article-title: IL-21 induces IL-22 production in CD4+ T cells publication-title: Nat. Commun. – volume: 108 start-page: 9560 year: 2011 end-page: 9565 ident: bib56 article-title: Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses publication-title: Proc. Natl. Acad. Sci. USA – volume: 53 start-page: 335 year: 2013 end-page: 344 ident: bib31 article-title: 3,3′-Diindolylmethane alleviates oxazolone-induced colitis through Th2/Th17 suppression and Treg induction publication-title: Mol. Immunol. – volume: 17 start-page: 1038 year: 1999 ident: bib47 article-title: Autoimmune disease drug discovery publication-title: Nat. Biotechnol. – volume: 361 start-page: 2033 year: 2009 end-page: 2045 ident: bib24 article-title: Inflammatory bowel disease and mutations affecting the interleukin-10 receptor publication-title: N. Engl. J. Med. – volume: 500 start-page: 232 year: 2013 end-page: 236 ident: bib3 article-title: Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota publication-title: Nature – volume: 125 start-page: 3886 year: 2015 end-page: 3895 ident: bib25 article-title: Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3 publication-title: Blood – volume: 304 start-page: 104 year: 2004 end-page: 107 ident: bib64 article-title: Development of a human adaptive immune system in cord blood cell-transplanted mice publication-title: Science – volume: 453 start-page: 106 year: 2008 end-page: 109 ident: bib66 article-title: The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins publication-title: Nature – volume: 198 start-page: 1875 year: 2003 end-page: 1886 ident: bib13 article-title: Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 publication-title: J. Exp. Med. – volume: 120 start-page: 68 year: 2011 end-page: 78 ident: bib7 article-title: Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn’s disease publication-title: Toxicol. Sci. – volume: 110 start-page: 1225 year: 2007 end-page: 1232 ident: bib8 article-title: Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression publication-title: Blood – volume: 13 start-page: 770 year: 2012 end-page: 777 ident: bib51 article-title: Aiolos promotes TH17 differentiation by directly silencing IL2 expression publication-title: Nat. Immunol. – volume: 149 start-page: 35 year: 1996 end-page: 53 ident: bib39 article-title: Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells publication-title: Immunol. Rev. – volume: 491 start-page: 119 year: 2012 end-page: 124 ident: bib34 article-title: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease publication-title: Nature – volume: 453 start-page: 65 year: 2008 end-page: 71 ident: bib49 article-title: Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor publication-title: Nature – volume: 27 start-page: 1743 year: 1997 end-page: 1750 ident: bib46 article-title: Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice publication-title: Eur. J. Immunol. – volume: 110 start-page: 2983 year: 2007 end-page: 2990 ident: bib65 article-title: Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype publication-title: Blood – volume: 375 start-page: 331 year: 2008 end-page: 335 ident: bib68 article-title: Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase publication-title: Biochem. Biophys. Res. Commun. – volume: 2 start-page: 748 year: 1961 end-page: 749 ident: bib42 article-title: Immunological function of the thymus publication-title: Lancet – volume: 27 start-page: 20 year: 2001 end-page: 21 ident: bib6 article-title: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 publication-title: Nat. Genet. – volume: 474 start-page: 307 year: 2011 end-page: 317 ident: bib36 article-title: Genetics and pathogenesis of inflammatory bowel disease publication-title: Nature – volume: 56 start-page: 2532 year: 2011 end-page: 2544 ident: bib22 article-title: A role of the aryl hydrocarbon receptor in attenuation of colitis publication-title: Dig. Dis. Sci. – volume: 389 start-page: 737 year: 1997 end-page: 742 ident: bib27 article-title: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis publication-title: Nature – volume: 32 start-page: 40 year: 2014 end-page: 51 ident: bib29 article-title: Clinical development success rates for investigational drugs publication-title: Nat. Biotechnol. – volume: 39 start-page: 386 year: 2013 end-page: 399 ident: bib48 article-title: Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora publication-title: Immunity – volume: 10 start-page: 490 year: 2010 end-page: 500 ident: bib55 article-title: FOXP3+ regulatory T cells in the human immune system publication-title: Nat. Rev. Immunol. – volume: 11 start-page: 846 year: 2010 end-page: 853 ident: bib23 article-title: Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells publication-title: Nat. Immunol. – volume: 365 start-page: 2055 year: 2011 end-page: 2066 ident: bib37 article-title: Interleukin-2 and regulatory T cells in graft-versus-host disease publication-title: N. Engl. J. Med. – volume: 33 start-page: 2801 year: 2003 end-page: 2810 ident: bib28 article-title: Functional CD25− and CD25+ mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application publication-title: Eur. J. Immunol. – volume: 92 start-page: 460 year: 2014 end-page: 465 ident: bib21 article-title: Identification of a probiotic bacteria-derived activator of the aryl hydrocarbon receptor that inhibits colitis publication-title: Immunol. Cell Biol. – volume: 32 start-page: 364 year: 2014 end-page: 372 ident: bib52 article-title: Development and function of human innate immune cells in a humanized mouse model publication-title: Nat. Biotechnol. – volume: 65 start-page: 584 year: 2016 end-page: 594 ident: bib11 article-title: Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn’s disease publication-title: Gut – volume: 185 start-page: 134 year: 2010 end-page: 143 ident: bib43 article-title: High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population publication-title: J. Immunol. – volume: 13 start-page: 24 year: 2014 ident: 10.1016/j.celrep.2016.09.082_bib5 article-title: Optimizing anti-TNF treatments in inflammatory bowel disease publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2013.06.002 – volume: 11 start-page: 846 year: 2010 ident: 10.1016/j.celrep.2016.09.082_bib23 article-title: Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells publication-title: Nat. Immunol. doi: 10.1038/ni.1915 – volume: 1 start-page: 539 year: 2009 ident: 10.1016/j.celrep.2016.09.082_bib35 article-title: Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes publication-title: Immunotherapy doi: 10.2217/imt.09.24 – volume: 182 start-page: 1281 year: 1995 ident: 10.1016/j.celrep.2016.09.082_bib45 article-title: Antibodies to interleukin 12 abrogate established experimental colitis in mice publication-title: J. Exp. Med. doi: 10.1084/jem.182.5.1281 – volume: 56 start-page: 2532 year: 2011 ident: 10.1016/j.celrep.2016.09.082_bib22 article-title: A role of the aryl hydrocarbon receptor in attenuation of colitis publication-title: Dig. Dis. Sci. doi: 10.1007/s10620-011-1643-9 – volume: 19 start-page: 1772 year: 2013 ident: 10.1016/j.celrep.2016.09.082_bib41 article-title: Induced and natural regulatory T cells in the development of inflammatory bowel disease publication-title: Inflamm. Bowel Dis. doi: 10.1097/MIB.0b013e318281f5a3 – volume: 375 start-page: 331 year: 2008 ident: 10.1016/j.celrep.2016.09.082_bib68 article-title: Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2008.07.156 – volume: 110 start-page: 2983 year: 2007 ident: 10.1016/j.celrep.2016.09.082_bib65 article-title: Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype publication-title: Blood doi: 10.1182/blood-2007-06-094656 – volume: 120 start-page: 68 year: 2011 ident: 10.1016/j.celrep.2016.09.082_bib7 article-title: Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn’s disease publication-title: Toxicol. Sci. doi: 10.1093/toxsci/kfq360 – volume: 21 start-page: 589 year: 2004 ident: 10.1016/j.celrep.2016.09.082_bib26 article-title: Human T regulatory cells can use the perforin pathway to cause autologous target cell death publication-title: Immunity doi: 10.1016/j.immuni.2004.09.002 – volume: 7 start-page: 443 year: 2007 ident: 10.1016/j.celrep.2016.09.082_bib53 article-title: TGFbeta signalling in control of T-cell-mediated self-reactivity publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2095 – volume: 198 start-page: 1875 year: 2003 ident: 10.1016/j.celrep.2016.09.082_bib13 article-title: Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 publication-title: J. Exp. Med. doi: 10.1084/jem.20030152 – volume: 474 start-page: 307 year: 2011 ident: 10.1016/j.celrep.2016.09.082_bib36 article-title: Genetics and pathogenesis of inflammatory bowel disease publication-title: Nature doi: 10.1038/nature10209 – volume: 6 start-page: e23522 year: 2011 ident: 10.1016/j.celrep.2016.09.082_bib59 article-title: Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis publication-title: PLoS ONE doi: 10.1371/journal.pone.0023522 – volume: 27 start-page: 405 year: 2015 ident: 10.1016/j.celrep.2016.09.082_bib14 article-title: The aryl hydrocarbon receptor/microRNA-212/132 axis in T cells regulates IL-10 production to maintain intestinal homeostasis publication-title: Int. Immunol. doi: 10.1093/intimm/dxv015 – volume: 149 start-page: 35 year: 1996 ident: 10.1016/j.celrep.2016.09.082_bib39 article-title: Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.1996.tb00898.x – volume: 174 start-page: 6477 year: 2005 ident: 10.1016/j.celrep.2016.09.082_bib58 article-title: Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells publication-title: J. Immunol. doi: 10.4049/jimmunol.174.10.6477 – volume: 491 start-page: 119 year: 2012 ident: 10.1016/j.celrep.2016.09.082_bib34 article-title: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease publication-title: Nature doi: 10.1038/nature11582 – volume: 5 start-page: 3199 year: 2014 ident: 10.1016/j.celrep.2016.09.082_bib19 article-title: TNF-α blockade induces IL-10 expression in human CD4+ T cells publication-title: Nat. Commun. doi: 10.1038/ncomms4199 – volume: 13 start-page: 770 year: 2012 ident: 10.1016/j.celrep.2016.09.082_bib51 article-title: Aiolos promotes TH17 differentiation by directly silencing IL2 expression publication-title: Nat. Immunol. doi: 10.1038/ni.2363 – volume: 49 year: 2002 ident: 10.1016/j.celrep.2016.09.082_bib57 article-title: Induction of TNBS colitis in mice publication-title: Curr. Protoc. Immunol. – volume: 32 start-page: 364 year: 2014 ident: 10.1016/j.celrep.2016.09.082_bib52 article-title: Development and function of human innate immune cells in a humanized mouse model publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2858 – volume: 27 start-page: 20 year: 2001 ident: 10.1016/j.celrep.2016.09.082_bib6 article-title: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 publication-title: Nat. Genet. doi: 10.1038/83713 – volume: 11 start-page: 854 year: 2010 ident: 10.1016/j.celrep.2016.09.082_bib1 article-title: The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27 publication-title: Nat. Immunol. doi: 10.1038/ni.1912 – volume: 125 start-page: 3886 year: 2015 ident: 10.1016/j.celrep.2016.09.082_bib25 article-title: Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3 publication-title: Blood doi: 10.1182/blood-2014-12-618363 – volume: 73 start-page: 251 year: 2006 ident: 10.1016/j.celrep.2016.09.082_bib10 article-title: The yin and yang of tumor necrosis factor inhibitors publication-title: Cleve. Clin. J. Med. doi: 10.3949/ccjm.73.3.251 – volume: 361 start-page: 2033 year: 2009 ident: 10.1016/j.celrep.2016.09.082_bib24 article-title: Inflammatory bowel disease and mutations affecting the interleukin-10 receptor publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0907206 – volume: 53 start-page: 335 year: 2013 ident: 10.1016/j.celrep.2016.09.082_bib31 article-title: 3,3′-Diindolylmethane alleviates oxazolone-induced colitis through Th2/Th17 suppression and Treg induction publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2012.09.007 – volume: 453 start-page: 65 year: 2008 ident: 10.1016/j.celrep.2016.09.082_bib49 article-title: Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor publication-title: Nature doi: 10.1038/nature06880 – volume: 17 start-page: 1149 year: 2011 ident: 10.1016/j.celrep.2016.09.082_bib2 article-title: Role of the xenobiotic receptor in inflammatory bowel disease publication-title: Inflamm. Bowel Dis. doi: 10.1002/ibd.21463 – volume: 453 start-page: 106 year: 2008 ident: 10.1016/j.celrep.2016.09.082_bib66 article-title: The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins publication-title: Nature doi: 10.1038/nature06881 – volume: 30 start-page: 531 year: 2012 ident: 10.1016/j.celrep.2016.09.082_bib33 article-title: Regulatory T cells: mechanisms of differentiation and function publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.immunol.25.022106.141623 – volume: 17 start-page: 1038 year: 1999 ident: 10.1016/j.celrep.2016.09.082_bib47 article-title: Autoimmune disease drug discovery publication-title: Nat. Biotechnol. doi: 10.1038/13748 – volume: 67 start-page: 259 year: 2015 ident: 10.1016/j.celrep.2016.09.082_bib18 article-title: The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology publication-title: Pharmacol. Rev. doi: 10.1124/pr.114.009001 – volume: 5 start-page: 3753 year: 2014 ident: 10.1016/j.celrep.2016.09.082_bib71 article-title: IL-21 induces IL-22 production in CD4+ T cells publication-title: Nat. Commun. doi: 10.1038/ncomms4753 – volume: 280 start-page: 14981 year: 2005 ident: 10.1016/j.celrep.2016.09.082_bib30 article-title: Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease publication-title: J. Biol. Chem. doi: 10.1074/jbc.M500966200 – volume: 75 start-page: 263 year: 1993 ident: 10.1016/j.celrep.2016.09.082_bib38 article-title: Interleukin-10-deficient mice develop chronic enterocolitis publication-title: Cell doi: 10.1016/0092-8674(93)80068-P – volume: 185 start-page: 134 year: 2010 ident: 10.1016/j.celrep.2016.09.082_bib43 article-title: High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population publication-title: J. Immunol. doi: 10.4049/jimmunol.0803474 – volume: 194 start-page: 146 year: 1962 ident: 10.1016/j.celrep.2016.09.082_bib9 article-title: Immunological function of thymus and bursa of Fabricius. Thymus lesions in an auto-immune disease of mice publication-title: Nature doi: 10.1038/194146a0 – volume: 204 start-page: 1257 year: 2007 ident: 10.1016/j.celrep.2016.09.082_bib15 article-title: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression publication-title: J. Exp. Med. doi: 10.1084/jem.20062512 – volume: 33 start-page: 2801 year: 2003 ident: 10.1016/j.celrep.2016.09.082_bib28 article-title: Functional CD25− and CD25+ mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application publication-title: Eur. J. Immunol. doi: 10.1002/eji.200324115 – volume: 10 start-page: 490 year: 2010 ident: 10.1016/j.celrep.2016.09.082_bib55 article-title: FOXP3+ regulatory T cells in the human immune system publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2785 – volume: 89 start-page: 817 year: 2011 ident: 10.1016/j.celrep.2016.09.082_bib63 article-title: Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis publication-title: Immunol. Cell Biol. doi: 10.1038/icb.2010.165 – volume: 60 start-page: 1958 year: 2015 ident: 10.1016/j.celrep.2016.09.082_bib32 article-title: Aryl hydrocarbon receptor activation down-regulates IL-7 and reduces inflammation in a mouse model of mouse model publication-title: Dig. Dis. Sci. doi: 10.1007/s10620-015-3632-x – volume: 107 start-page: 20768 year: 2010 ident: 10.1016/j.celrep.2016.09.082_bib50 article-title: An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1009201107 – volume: 365 start-page: 2067 year: 2011 ident: 10.1016/j.celrep.2016.09.082_bib54 article-title: Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1105143 – volume: 500 start-page: 232 year: 2013 ident: 10.1016/j.celrep.2016.09.082_bib3 article-title: Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota publication-title: Nature doi: 10.1038/nature12331 – volume: 110 start-page: 1225 year: 2007 ident: 10.1016/j.celrep.2016.09.082_bib8 article-title: Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression publication-title: Blood doi: 10.1182/blood-2006-12-064527 – volume: 65 start-page: 584 year: 2016 ident: 10.1016/j.celrep.2016.09.082_bib11 article-title: Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn’s disease publication-title: Gut doi: 10.1136/gutjnl-2014-306919 – volume: 2 start-page: 748 year: 1961 ident: 10.1016/j.celrep.2016.09.082_bib42 article-title: Immunological function of the thymus publication-title: Lancet doi: 10.1016/S0140-6736(61)90693-6 – volume: 92 start-page: 460 year: 2014 ident: 10.1016/j.celrep.2016.09.082_bib21 article-title: Identification of a probiotic bacteria-derived activator of the aryl hydrocarbon receptor that inhibits colitis publication-title: Immunol. Cell Biol. doi: 10.1038/icb.2014.2 – volume: 51 start-page: 2109 year: 2009 ident: 10.1016/j.celrep.2016.09.082_bib72 article-title: Activation of aryl hydrocarbon receptor suppresses experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.09-3993 – volume: 365 start-page: 2055 year: 2011 ident: 10.1016/j.celrep.2016.09.082_bib37 article-title: Interleukin-2 and regulatory T cells in graft-versus-host disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1108188 – volume: 32 start-page: 40 year: 2014 ident: 10.1016/j.celrep.2016.09.082_bib29 article-title: Clinical development success rates for investigational drugs publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2786 – volume: 27 start-page: 1743 year: 1997 ident: 10.1016/j.celrep.2016.09.082_bib46 article-title: Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice publication-title: Eur. J. Immunol. doi: 10.1002/eji.1830270722 – volume: 65 start-page: 1642 year: 2016 ident: 10.1016/j.celrep.2016.09.082_bib20 article-title: Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo publication-title: Gut doi: 10.1136/gutjnl-2015-310022 – volume: 61 start-page: 476 year: 2012 ident: 10.1016/j.celrep.2016.09.082_bib4 article-title: Inflammatory bowel disease therapies and cancer risk: where are we and where are we going? publication-title: Gut doi: 10.1136/gutjnl-2011-301133 – volume: 6 start-page: e23618 year: 2011 ident: 10.1016/j.celrep.2016.09.082_bib69 article-title: In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling publication-title: PLoS ONE doi: 10.1371/journal.pone.0023618 – volume: 23 start-page: 92 year: 2015 ident: 10.1016/j.celrep.2016.09.082_bib12 article-title: Biotherapies targeting T and B cells: from immune suppression to immune tolerance publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2015.05.013 – volume: 88 start-page: 685 year: 2010 ident: 10.1016/j.celrep.2016.09.082_bib62 article-title: Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice publication-title: Immunol. Cell Biol. doi: 10.1038/icb.2010.35 – volume: 12 start-page: 383 year: 2011 ident: 10.1016/j.celrep.2016.09.082_bib61 article-title: Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 publication-title: Nat. Immunol. doi: 10.1038/ni.2025 – volume: 314 start-page: 1461 year: 2006 ident: 10.1016/j.celrep.2016.09.082_bib17 article-title: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene publication-title: Science doi: 10.1126/science.1135245 – volume: 109 start-page: 11270 year: 2012 ident: 10.1016/j.celrep.2016.09.082_bib70 article-title: Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1120611109 – volume: 21 start-page: 638 year: 2015 ident: 10.1016/j.celrep.2016.09.082_bib40 article-title: Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α publication-title: Nat. Med. doi: 10.1038/nm.3868 – volume: 39 start-page: 386 year: 2013 ident: 10.1016/j.celrep.2016.09.082_bib48 article-title: Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora publication-title: Immunity doi: 10.1016/j.immuni.2013.08.002 – volume: 141 start-page: 237 year: 2011 ident: 10.1016/j.celrep.2016.09.082_bib44 article-title: Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.04.007 – volume: 304 start-page: 104 year: 2004 ident: 10.1016/j.celrep.2016.09.082_bib64 article-title: Development of a human adaptive immune system in cord blood cell-transplanted mice publication-title: Science doi: 10.1126/science.1093933 – volume: 143 year: 2012 ident: 10.1016/j.celrep.2016.09.082_bib16 article-title: Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn’s disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.07.116 – volume: 99 start-page: 14694 year: 2002 ident: 10.1016/j.celrep.2016.09.082_bib60 article-title: A ligand for the aryl hydrocarbon receptor isolated from lung publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.232562899 – volume: 389 start-page: 737 year: 1997 ident: 10.1016/j.celrep.2016.09.082_bib27 article-title: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis publication-title: Nature doi: 10.1038/39614 – volume: 206 start-page: 43 year: 2009 ident: 10.1016/j.celrep.2016.09.082_bib67 article-title: Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells publication-title: J. Exp. Med. doi: 10.1084/jem.20081438 – volume: 108 start-page: 9560 year: 2011 ident: 10.1016/j.celrep.2016.09.082_bib56 article-title: Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1017854108
SSID	ssj0000601194
Score	2.5338097
Snippet	Existing therapies for inflammatory bowel disease that are based on broad suppression of inflammation result in variable clinical benefit and unwanted side... Existing therapies for inflammatory bowel disease based on broad suppression of inflammation result in variable clinical benefit and unwanted side effects. A...
SourceID	doaj pubmedcentral proquest pubmed crossref elsevier
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	1318
SubjectTerms	AHR Animals Colitis - immunology Colitis - metabolism Disease Models, Animal Forkhead Transcription Factors - metabolism humanized mice Humans IBD ITE Mice Receptors, Aryl Hydrocarbon - metabolism T-Lymphocytes, Regulatory - immunology Thiazoles Transforming Growth Factor beta1 - pharmacology treg Trinitrobenzenesulfonic Acid
Title	AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice
URI	https://dx.doi.org/10.1016/j.celrep.2016.09.082 https://www.ncbi.nlm.nih.gov/pubmed/27783946 https://www.proquest.com/docview/1835683320 https://pubmed.ncbi.nlm.nih.gov/PMC5106873 https://doaj.org/article/bd474ed541e14d95abfd2e1ea5239614
Volume	17
WOSCitedRecordID	wos000386527100011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ - Directory of Open Access Journals customDbUrl: eissn: 2211-1247 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000601194 issn: 2211-1247 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9QwFLagAokLKvtAqYzENWLiNT4O01ZFgmqECpqb5eUZgkYpmmmRyq_HSzKawGEuXLM5b_F7z_HL9yH01tbGgQ22EuBUxRiVlSU-VMZQrxQP3OSuyq8f5cVFs1yqxQ7VV-oJK_DARXHvrGeSgeeshpp5xY0NnkANJq6glMgU1iRWPTuLqRKDE5ZZ2lImJPVsESaH_-Zyc5eD1RoSXGUtMsxpQ0Z5KcP3j9LTv-Xn312UO2np7BA97OtJPCtyPEJ3oHuM7heGydsnaDE7_4xnbuAwwx82eFGQGWKUw-abaWN5iOe5CW6DT9Yp9mF7iy_xHFarDW47nD_zt7_B408xqDxFX85OL-fnVU-iUDlO1HWlAGIOtiRRHgZqmOHUWsob4RtivHAeTB143QRGgQSQVEajseC8EtGO0tBn6KC76uAFwkY1XllmKFGBcTI1gQsgMZ8BCO-UmyA6qFC7HmE8EV2s9NBK9kMXxeukeD1VOip-gqrtXT8Lwsae698n62yvTfjY-UD0Gt17jd7nNRMkB9vqvtQoJUR8VLtn-DeDK-g4E9P2iung6majY3DkoqGUTCfoeXGN7UsSKWMlykQcd-Q0IynGZ7r2e0b7jkFTNJK-_B9iv0IPkigp9xJ-hA6u1zfwGt1zv6KPrY_RXblsjvNE-gNrKyI3
linkProvider	Directory of Open Access Journals
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=AHR+activation+is+protective+against+colitis+driven+by+T+cells+in+humanized+mice&rft.jtitle=Cell+reports+%28Cambridge%29&rft.au=Goettel%2C+Jeremy+A.&rft.au=Gandhi%2C+Roopali&rft.au=Kenison%2C+Jessica+E.&rft.au=Yeste%2C+Ada&rft.date=2016-10-25&rft.eissn=2211-1247&rft.volume=17&rft.issue=5&rft.spage=1318&rft.epage=1329&rft_id=info:doi/10.1016%2Fj.celrep.2016.09.082&rft_id=info%3Apmid%2F27783946&rft.externalDocID=PMC5106873
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-1247&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-1247&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-1247&client=summon